Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Unaudited Consolidated Statements of Comprehensive Loss

v3.19.3
Condensed Unaudited Consolidated Statements of Comprehensive Loss - CAD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Condensed Unaudited Consolidated Statements of Comprehensive Loss        
Revenue $ 200,068 $ 189,902 $ 461,334 $ 635,401
Cost of revenue 134,470 140,095 397,274 435,414
Gross profit 65,598 49,807 64,060 199,987
Operating expenses        
Amortization 268,932 68,917 798,912 197,332
General and administrative expenses 2,323,858 1,686,525 5,828,196 3,595,998
Research and development expenses 3,266,756 905,811 6,825,816 4,184,587
Sales and marketing expenses 452,808 356,806 1,265,346 833,050
Stock-based compensation expense 1,597,779 644,228 4,148,806 2,528,643
Share-based payment expense (recovery) (39,426) 312,960 206,516 935,837
Operating expense 7,870,707 3,975,247 19,073,592 12,275,447
Loss before other items (7,805,109) (3,925,440) (19,009,532) (12,075,460)
Other items        
Interest income 152,561   94,478  
Issue costs allocated to derivative liability   (627,821)   (627,821)
Changes in fair value of derivative liability 2,107,474 1,919,072 (3,412,917) 4,945,126
Other income 17,711   71,639  
Foreign exchange gain (loss) 186,848 (256,131) (479,721) (152,354)
Loss before taxes (5,340,515) (2,890,320) (22,736,053) (7,910,509)
Current income tax expense     2,140  
Deferred income tax recovery (6,894)   (56,069)  
Net loss (5,333,621) (2,890,320) (22,682,124) (7,910,509)
Other comprehensive income - foreign currency translation 14,257 250 (10,330)  
Comprehensive loss $ (5,347,878) $ (2,890,570) $ (22,671,794) $ (7,910,509)
Loss per share - basic and fully diluted (in dollars per share) $ (0.14) $ (0.11) $ (0.64) $ (0.31)
Weighted average number of shares outstanding - basic and fully diluted (in shares) 36,957,731 26,687,607 35,651,311 25,287,764